A charter to improve care for systemic lupus erythematosus.

IF 3.4 4区 医学 Q2 RHEUMATOLOGY
Marta Mosca, Jeanette Andersen, Patrick Wildman, Susan Manzi, Zahir Amoura, Irene Bultink, Odirlei Andre Monticielo, Sandra Navarra, Susanne Pettersson
{"title":"A charter to improve care for systemic lupus erythematosus.","authors":"Marta Mosca, Jeanette Andersen, Patrick Wildman, Susan Manzi, Zahir Amoura, Irene Bultink, Odirlei Andre Monticielo, Sandra Navarra, Susanne Pettersson","doi":"10.55563/clinexprheumatol/my79eu","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To develop evidenced recommendations to allow the global systemic lupus erythematosus (SLE) advocacy community to effectively advocate for change and improve care for patients with SLE.</p><p><strong>Methods: </strong>A Global Working Group consisting of representatives from patient advocacy groups, professional organisations, and the SLE healthcare community defined key areas of unmet need in patients with SLE. Targeted principles for each area of unmet need guided a literature review to investigate the current global situation, pre-existing advocacy efforts, and best practices from other therapy areas. The results from this literature review allowed the Working Group to develop recommendations to improve care for patients with SLE.</p><p><strong>Results: </strong>Barriers faced by patients with SLE can stem from poor recognition of symptoms, which leads to delays in accurate diagnosis, cycling between different healthcare professionals, and inconsistencies in receiving optimal care. Patient access to approved treatments for SLE also remains limited. This Patient Charter, co-developed with a group of internationally recognised clinicians and patient advocates, sets out the minimum standard of care people living with SLE should expect and receive under 4 principles with distinct recommendations for change.</p><p><strong>Conclusions: </strong>The intention is to improve health outcomes by uniting and empowering patients, caregivers, patient groups, and healthcare professionals to advocate for reforms to healthcare practices for people living with SLE.</p>","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and experimental rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.55563/clinexprheumatol/my79eu","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To develop evidenced recommendations to allow the global systemic lupus erythematosus (SLE) advocacy community to effectively advocate for change and improve care for patients with SLE.

Methods: A Global Working Group consisting of representatives from patient advocacy groups, professional organisations, and the SLE healthcare community defined key areas of unmet need in patients with SLE. Targeted principles for each area of unmet need guided a literature review to investigate the current global situation, pre-existing advocacy efforts, and best practices from other therapy areas. The results from this literature review allowed the Working Group to develop recommendations to improve care for patients with SLE.

Results: Barriers faced by patients with SLE can stem from poor recognition of symptoms, which leads to delays in accurate diagnosis, cycling between different healthcare professionals, and inconsistencies in receiving optimal care. Patient access to approved treatments for SLE also remains limited. This Patient Charter, co-developed with a group of internationally recognised clinicians and patient advocates, sets out the minimum standard of care people living with SLE should expect and receive under 4 principles with distinct recommendations for change.

Conclusions: The intention is to improve health outcomes by uniting and empowering patients, caregivers, patient groups, and healthcare professionals to advocate for reforms to healthcare practices for people living with SLE.

改善系统性红斑狼疮护理的宪章。
目的制定有据可依的建议,使全球系统性红斑狼疮(SLE)宣传团体能够有效地倡导变革,改善对系统性红斑狼疮患者的护理:由患者权益团体、专业组织和系统性红斑狼疮医疗界代表组成的全球工作组确定了系统性红斑狼疮患者尚未满足需求的关键领域。每个未满足需求领域的目标原则指导了文献综述,以调查全球现状、已有的宣传工作以及其他治疗领域的最佳实践。根据文献综述的结果,工作组提出了改善系统性红斑狼疮患者护理的建议:系统性红斑狼疮患者面临的障碍可能源于对症状的认识不足,这导致了准确诊断的延误、不同医护人员之间的循环以及接受最佳治疗的不一致。此外,患者获得已获批准的系统性红斑狼疮治疗方法的机会仍然有限。这份《患者宪章》是由一群国际知名的临床医生和患者权益倡导者共同制定的,它根据四项原则列出了系统性红斑狼疮患者应期待和接受的最低医疗标准,并提出了明确的改革建议:该宪章的目的是通过联合患者、护理人员、患者团体和医疗保健专业人员并赋予他们权力,倡导对系统性红斑狼疮患者的医疗保健实践进行改革,从而改善健康状况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.10
自引率
18.90%
发文量
377
审稿时长
3-6 weeks
期刊介绍: Clinical and Experimental Rheumatology is a bi-monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信